Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy
- PMID: 26156078
- DOI: 10.1093/annonc/mdv287
Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy
Comment in
-
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al.Ann Oncol. 2015 Oct;26(10):2196-7. doi: 10.1093/annonc/mdv301. Epub 2015 Jul 20. Ann Oncol. 2015. PMID: 26193885 No abstract available.
Comment on
-
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.Ann Oncol. 2015 May;26(5):987-991. doi: 10.1093/annonc/mdv037. Epub 2015 Feb 16. Ann Oncol. 2015. PMID: 25688058 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical